Table 1.
In vitro DPPH and FRAP profile of the synthesized compounds. Each value is the mean of at least three different experiments (mean ± SEM). * Limit of quantification (LOQ).
| Compound | DPPH (% Inhibition) |
DPPH IC50 (µg/mL) |
FRAP (µmolTE/g) |
|---|---|---|---|
| Caffeic acid | 79.95 ± 0.88 | 5.26 ± 0.41 | 10,160.24 ± 21.48 |
| PBSA | <LOQ * | - | <LOQ * |
| BZTidr1 | 10.95 ± 0.12 | - | 282.16 ± 15.03 |
| BZTidr2 | 54.80 ± 1.63 | - | 1160.24 ± 17.34 |
| BZTidr3 | 24.25 ± 1.38 | - | 273.99 ± 10.12 |
| BZTidr4 | >90.00 | 3.27 ± 0.21 | 5506.15 ± 120.52 |
| BZTidr5 | 44.00 ± 3.56 | - | 1758.16 ± 60.41 |
| BZTidr6 | >90.00 | 26.22 ± 1.81 | 3826.51 ± 90.60 |
| BZTcin1 | 0.51 ± 0.27 | - | 98.69 ± 2.06 |
| BZTcin2 | 12.37 ± 0.00 | - | 43.73 ± 2.83 |
| BZTcin3 | 5.77 ± 0.00 | - | 42.12 ± 1.35 |
| BZTcin4 | >90.00 | 4.86 ± 0.38 | 4583.10 ± 22.68 |
| BZTcin5 | 40.15 ± 0.18 | - | 2043.33 ± 12.03 |